Track topics on Twitter Track topics that are important to you
Tuesday, September 20th 2016 at 12:19pm UTC Un projet ambitieux de 3,2M EUR sur la validation clinique de l’efficacité du produit THN201 dans le traitement des troubles neurocognitifs dans la malad...
Tuesday, May 17th 2016 at 1:28pm UTC A major result for the company that validates for the first time in man its approach of combining a CNS drug with a glial connexin modulator LYON, France–(BU...
French-based, clinical-stage biopharmaceutical company Theranexus has reported positive results from its proof of concept clinical trial of THN102, to treat excessive daytime sleepiness (EDS) induced ...
A major result for the company that validates for the first time in man its approach of combining a CNS drug with a glial connexin modulator Read more...
Phase II entry of THN102 Theranexus, a biopharmaceutical company already in the clinical trial stages of its lead project, has announced the publication of an article i...
We have published hundreds of Theranexus news stories on BioPortfolio along with dozens of Theranexus Clinical Trials and PubMed Articles about Theranexus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theranexus Companies in our database. You can also find out about relevant Theranexus Drugs and Medications on this site too.